Claims
- 1. A stent for implantation in a blood vessel, wherein the stent is coated with Y-27632.
- 2. A stent for implantation in a blood vessel, wherein the stent is coated with a compound having the structure:
- 3. A stent for implantation in a blood vessel, wherein-the stent is coated with a compound having the structure:
- 4. A stent for implantation in a blood vessel, wherein the stent is coated with a compound having the structure:
- 5. A stent for implantation in a blood vessel, wherein the stent is coated with a compound comprising an amide compound having the structure:
- 6. A stent for implantation in a blood vessel, wherein the stent is coated with a compound having the structure:
- 7. A stent for implantation in a blood vessel, wherein the stent is coated with an inhibitor of Rho kinase.
- 8. The stent of any one of claims 1-7, wherein the stent is also coated with one or more of rapamycin, taxol, actinomycin D, heparin, C3 exoenzyme, or an inhibitor of RhoA.
- 9. A method of treating restenosis in a subject which comprises implanting in the subject the stent of any one of claims 1-7.
- 10. The method of claim 9, wherein the restenosis occurs after angioplasty or vascular stent placement.
- 11. The method of claim 10, wherein the restenosis occurs after coronary artery stent placement, peripheral artery stent placement, or cerebral artery stent placement.
Parent Case Info
[0001] This application claims priority of provisional application U.S. Ser. No. 60/388,760, filed Jun. 14, 2002, the contents of which are incorporated herein by reference.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60388760 |
Jun 2002 |
US |
|
60388769 |
Jun 2002 |
US |